Acute liver failure
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
| Acute liver failure Classification and external resources | |
| ICD-10 | K72.9 |
|---|---|
| MeSH | D017114 |
Acute liver failure is the appearance of severe complications rapidly after the first signs of liver disease (such as jaundice), and indicates that the liver has sustained severe damage (loss of function of 80-90% of liver cells). The complications are hepatic encephalopathy and impaired protein synthesis (as measured by the levels of serum albumin and the prothrombin time in the blood). The 1993 classification defines hyperacute as within 1 week, acute as 8-28 days and subacute as 4-12 weeks.[1] It reflects the fact that the pace of disease evolution strongly influence prognosis. Underlying aetiology is the other significant determinant of outcome.[2]
Causes
Common causes for acute liver failure are paracetamol (acetaminophen) overdose, idiosyncratic reaction to medication (e.g. tetracycline, troglitazone), excessive alcohol intake (severe alcoholic hepatitis), viral hepatitis (hepatitis A or B - it is extremely uncommon in hepatitis C), acute fatty liver of pregnancy, and idiopathic (without an obvious cause). Reye syndrome is acute liver failure in a child with a viral infection (e.g. chickenpox); it appears that aspirin use may play a significant role. Wilson's disease (hereditary copper accumulation) may infrequently present with acute liver failure.
Pathology
In the majority of acute liver failure (ALF) there is widespread hepatocellular necrosis beginning in the centrizonal distribution and progressing towards portal tracts. The degree of parenchymal inflammation is variable and is proportional to duration of disease[3][4].
Differential Diagnosis
- Acute fatty liver of pregnancy
- Autoimmune chronic active hepatitis
- Budd-Chiari Syndrome
- Cytomegalovirus
- Drugs
- Epstein-Barr Virus
- Heatstroke
- Hepatic arterial occlusion or Hepatic venous occlusion
- Hepatitis A - Hepatitis G
- Herpes simplex 1, 2
- Hypotension
- Hypothermia
- Massive malignant infiltration of the liver
- Parainfluenza virus
- Paramyxovirus
- Primary graft nonfunction post liver transplantation
- Reye's Syndrome
- Sepsis
- Shock
- Wilson's Disease
Clinical consequence
- Cerebral oedema and encephalopathy
In ALF, cerebral oedema leads to hepatic encephalopathy, coma, brain herniation and eventually death. Detection of encephalopathy is central to the diagnosis of ALF. It may vary from subtle defecit in higher brain function (e.g. mood, concentration in grade I) to deep coma (grade IV). Patients presenting as acute and hyperacute liver failure are at greater risk of developing cerebral oedema and grade IV encephalopathy. The pathogenesis remains unclear but is likely to be a consequence of several phenomenon. There is a build up of toxic substances like ammonia, mercaptan, endogenous benzodiazepines and serotonin/tryptophan in the brain. This affects neurotransmitter level and neuroreceptor activation. Autoregulation of cerebral blood flow is impaired and is associated with anaerobic glycolysis and oxidative stress. Neuronal cell astrocytes are susceptible to these changes and they swell up, resulting in increased intracranial pressure. Inflammatory mediators also play important role[5][6][2].
Unfortunately, signs of elevated intracranial pressure such as papilloedema and loss of pupillary reflexes are not reliable and occur late in the disease process. CT imaging of the brain is also unhelpful in detecting early cerebral oedema but is often performed to rule out intra-cerebral bleeding. Invasive intracranial pressure monitoring via subdural route is often recommended, however the risk of complications must be weighed against the possible benefit (1% fatal haemorrhage).[7] The aim is to maintain intracranial pressures below 25 mmHg, cerebral perfusion pressures above 50 mm Hg[2].
- Coagulopathy
Coagulopathy is another cardinal feature of ALF. Liver has central role in synthesis of almost all coagulation factors and some inhibitors of coagulation and fibrinolysis. Hepatocellular necrosis leads to impaired synthesis of many coagulation factors and their inhibitors. the former produces a prolongation in Prothrombin time which is widely used to monitor severity of hepatic injury.There is significant platelet dysfunction (with both quantitative and qualitative platelet defects). Progressive thrombocytopenia with loss of larger and more active platelet is almost universal. Thrombocytopenia with or without DIC increases risk of intracerebral bleeding[4].
- Renal failure
Renal failure is common, present in more than 50% of ALF patients, either due to original insult such as paracetamol resulting in acute tubular necrosis or from hyperdynamic circulation leading to hepatorenal syndrome or functional renal failure. Because of impaired production of urea, blood urea do not represent degree of renal impairment.
- Inflammation and infection
About 60% of all ALF patients fulfil the criteria for systemic inflammatory syndrome irrespective of presence or absence of infection[8]. This often contributes towards multi organ failure. Impaired host defence mechanism due to impaired opsonisation, chemotaxis and intracellular killing substantially increase risk of sepsis. Bacterial sepsis mostly due to gram positive organisms and fungal sepsis are observed in up to 80% and 30% patients respectively[4].
- Metabolic derangements
Hyponatraemia is almost universal finding due to water retention and shift in intracellular sodium transport from inhibition of Na/K ATPase. Hypoglycaemia (due to depleted hepatic glycogen store and hyperinsulinaemia), hypokalaemia, hypophosphataemia and Metabolic alkalosis are often present independent of renal function. Lactic acidosis occurs predominantly in paracetamol overdose.
- Haemodynamic and cardio-respiratory compromise
Hyperdynamic circulation with peripheral vasodilatation from low systemic vascular resistance leads to hypotension. There is a compensatory increase in cardiac output. Adrenal insufficiency has been documented in 60% of ALF and is likely to contribute in haemodynamic compromise[9]. There is also abnormal oxygen transport and utilization. Although delivery of oxygen to the tissues is adequate, there is a decrease in tissue oxygen uptake, resulting in tissue hypoxia and lactic acidosis[10].
Pulmonary complications occur in up to 50% patients[11]. Severe lung injury and hypoxemia result in high mortality. Most cases of severe lung injury is due to ARDS with or without sepsis. Pulmonary haemorrhage, pleural effusions, atelectasis, and intrapulmonary shunts also contribute to respiratory difficulty.
Evaluation
All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged by ≈ 4-6 seconds or more (INR ≥1.5) and there is any evidence of altered sensorium, the diagnosis of ALF should be strongly suspected and hospital admission is mandatory[12]. Initial laboratory examination must be extensive in order to evaluate both the aetiology and severity.
- Initial laboratory analysis[12]
- Prothrombin time/INR
- Complete blood count
- Chemistries
- Liver function test: AST, ALT, alkaline phosphatase, GGT, total bilirubin, albumin
- Creatinine, urea/blood urea nitrogen, sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphate
- glucose
- Amylase and lipase
- Arterial blood gas, lactate
- Blood type and screen
- Paracetamol (Acetaminophen) level, Toxicology screen
- Viral hepatitis serologies: anti-HAV IgM, HBSAg, anti-HBc IgM, anti-HEV
- Autoimmune markers: ANA, ASMA, LKMA, Immunoglobulin levels
- Ceruloplasmin Level ( when Wilson's disease suspected)
- Pregnancy test (females)
- Ammonia (arterial if possible)
- HIV status (has implication for transplantation)
History taking should include careful review of possible exposures to viral infection and drugs or other toxins. From history and clinical examination possibility of underlying chronic disease should be ruled out as it may have different management.
A liver biopsy done via the transjugular route because of coagulopathy is not usually necessary other than in occasional malignancies. As the evaluation continues, several important decisions have to be made such as whether to admit the patient to an ICU, or whether to transfer the patient to a transplant facility. Consultation with the transplant centre as early as possible is critical due to possibility of rapid progression of ALF.
Treatment
| King's College Hospital criteria for liver transplantation in acute liver failure[13] |
| Patients with paracetamol toxicity pH <7.3 or |
| Other patients Prothrombin time >100 seconds or |
Treatment involves admission to hospital; often intensive care unit admission or very close observation are required. Supportive treatment is with adequate nutrition, optimalisation of the fluid balance, mechanical ventilation and intracranial pressure monitoring (in severe encephalopathy), and treatment aimed at removing the underlying cause (such as acetylcysteine for paracetamol poisoning). Other supportive measures may include the drainage of ascites.
While many people who develop acute liver failure recover with supportive treatment, liver transplantation is often required in people who continue to deteriorate or have adverse prognostic factors.
"Liver dialysis" (various measures to replace normal liver function) is evolving as a treatment modality and is gradually being introduced in the care of patients with liver failure.
Prognosis
Historically morta lity has been unacceptably high, being in excess of 80%[14]. In recent years the advent of liver transplantation and multidisciplinary intensive care support have improved survival significantly. At present overall short term survival with transplant is more than 65%[15].
Several prognostic scoring systems have been devised to predict mortality and to identify who will require early liver transplant. These include kings college hospital criteria, MELD score, APACHE II and Clichy criteria.
Terminology
To date no universally accepted nomenclature has been adopted. Trey and Davidson introduced the term fulminant hepatic failure in 1970 to describe "potentially reversible condition, the consequence of severe liver injury, with an onset of encephalopathy within 8 weeks of the appearance of the first symptoms and in the absence of pre-existing liver disease"[16]. Later it was suggested that the term fulminant should be confined to patients who develop jaundice to encephalopathy within 2 weeks. Terms subfulminant hepatic failure and late onset hepatic failure were coined for onset between 2 weeks to 3 months and for 8 weeks to 24 weeks respectively[17][18]. The umbrella term of acute liver failure was proposed by Kings college group which has been adopted in this article. Paradoxically in this classification the best prognosis is in the hyperacute group[19].
Related Images
 Diagram of hepatobiliary system |
 Acute liver failure from Marburg virus, a rare cause. Note hepatocellular necrosis and sinusoidal bleeding |
 Liver transplant |
References
- ↑ O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5. PMID 8101303.
- ↑ 2.0 2.1 2.2 O'Grady JG (2005). "Acute liver failure". Postgraduate medical journal 81 (953): 148-54. doi:10.1136/pgmj.2004.026005. PMID 15749789.
- ↑ Boyer JL, Klatskin G (1970). "Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis)". N. Engl. J. Med. 283 (20): 1063-71. PMID 4319402.
- ↑ 4.0 4.1 4.2 Gimson AE (1996). "Fulminant and late onset hepatic failure". British journal of anaesthesia 77 (1): 90-8. PMID 8703634.
- ↑ Hazell AS, Butterworth RF (1999). "Hepatic encephalopathy: An update of pathophysiologic mechanisms". Proc. Soc. Exp. Biol. Med. 222 (2): 99-112. PMID 10564534.
- ↑ Larsen FS, Wendon J (2002). "Brain edema in liver failure: basic physiologic principles and management". Liver Transpl. 8 (11): 983-9. doi:10.1053/jlts.2002.35779. PMID 12424710.
- ↑ Armstrong IR, Pollok A, Lee A (1993). "Complications of intracranial pressure monitoring in fulminant hepatic failure". Lancet 341 (8846): 690-1. PMID 8095592.
- ↑ Schmidt LE, Larsen FS (2006). "Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure". Crit. Care Med. 34 (2): 337-43. PMID 16424712.
- ↑ Harry R, Auzinger G, Wendon J (2002). "The clinical importance of adrenal insufficiency in acute hepatic dysfunction". Hepatology 36 (2): 395-402. doi:10.1053/jhep.2002.34514. PMID 12143048.
- ↑ Bihari D, Gimson AE, Waterson M, Williams R (1985). "Tissue hypoxia during fulminant hepatic failure". Crit. Care Med. 13 (12): 1034-9. PMID 3933911.
- ↑ Trewby PN, Warren R, Contini S, et al (1978). "Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure". Gastroenterology 74 (5 Pt 1): 859-65. PMID 346431.
- ↑ 12.0 12.1 Polson J, Lee WM (2005). "AASLD position paper: the management of acute liver failure". Hepatology 41 (5): 1179-97. doi:10.1002/hep.20703. PMID 15841455.
- ↑ O'Grady JG, Alexander GJ, Hayllar KM, Williams R (1989). "Early indicators of prognosis in fulminant hepatic failure". Gastroenterology 97 (2): 439-45. PMID 2490426.
- ↑ Rakela J, Lange SM, Ludwig J, Baldus WP (1985). "Fulminant hepatitis: Mayo Clinic experience with 34 cases". Mayo Clin. Proc. 60 (5): 289-92. PMID 3921780.
- ↑ Ostapowicz G, Fontana RJ, Schiødt FV, et al (2002). "Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States". Ann. Intern. Med. 137 (12): 947-54. PMID 12484709.
- ↑ Trey C, Davidson CS (1970). "The management of fulminant hepatic failure". Progress in liver diseases 3: 282-98. PMID 4908702.
- ↑ Bernuau J, Goudeau A, Poynard T, et al (1986). "Multivariate analysis of prognostic factors in fulminant hepatitis B". Hepatology 6 (4): 648-51. PMID 3732998.
- ↑ Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R (1986). "Late onset hepatic failure: clinical, serological and histological features". Hepatology 6 (2): 288-94. PMID 3082735.
- ↑ Sass DA, Shakil AO (2005). "Fulminant hepatic failure". Liver Transpl. 11 (6): 594-605. doi:10.1002/lt.20435. PMID 15915484.
External links
- Acute Hepatic Failure - emedicine.com article.
- Fulminant Hepatic Failure - emedicine.com article.
Health Science · Medicine · Medical specialities · Intensive care medicine / Critical care medicine and Critical care nursing | |||||||
|---|---|---|---|---|---|---|---|
| General terms | Intensive care unit (ICU) · Neonatal intensive care unit (NICU) · Pediatric intensive care unit (PICU) · Coronary care unit (CCU) · Critical illness insurance | ||||||
| Conditions |
| ||||||
| Diagnosis | Arterial blood gas · Arterial catheter · Blood cultures · Central venous catheter · Pulmonary artery catheter · Screening cultures | ||||||
| Life supporting treatments | Airway management · Chest tube · Dialysis · Enteral feeding · Goal-directed therapy · Induced coma · Mechanical ventilation · Therapeutic hypothermia · Total parenteral nutrition | ||||||
| Drugs | Analgesics · Antibiotics · Antithrombotics · Inotropes · Intravenous fluids · Neuromuscular-blocking drugs · Recombinant activated protein C · Sedatives · Stress ulcer prevention drugs · Vasopressors | ||||||
| ICU scoring systems | APACHE II · Glasgow Coma Scale · PIM2 · SAPS II · SAPS III · SOFA | ||||||
| Organisations | Society of Critical Care Medicine · Surviving Sepsis Campaign | ||||||
| Related specialties | Anesthesia · Cardiology · Internal medicine · Neurology · Pediatrics · Pulmonology · Surgery · Traumatology | ||||||
WikiDoc Research Resources for Acute liver failure | |
|---|---|
| Articles on Acute liver failure | Most recent articles on Acute liver failure • Most cited articles on Acute liver failure • Review articles on Acute liver failure • Articles on Acute liver failure in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Acute liver failure | Powerpoint slides on Acute liver failure • Images of Acute liver failure • Photos of Acute liver failure • Podcasts & MP3s on Acute liver failure • Videos on Acute liver failure |
| Evidence Based Medicine Regarding Acute liver failure | Cochrane Collaboration on Acute liver failure • Bandolier on Acute liver failure • TRIP on Acute liver failure |
| Cost Effectiveness of Acute liver failure | Cost Effectiveness of Acute liver failure |
| Clinical Trials Involving Acute liver failure | Ongoing Trials on Acute liver failure at Clinical Trials.gov • Trial results on Acute liver failure • Clinical Trials on Acute liver failure at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Acute liver failure | US National Guidelines Clearinghouse on Acute liver failure • NICE Guidance on Acute liver failure • NHS PRODIGY Guidance • FDA on Acute liver failure • CDC on Acute liver failure |
| Textbook Information on Acute liver failure | Books and Textbook Information on Acute liver failure |
| Pharmacology Resources on Acute liver failure | Dosing of Acute liver failure • Drug interactions with Acute liver failure • Side effects of Acute liver failure • Allergic reactions to Acute liver failure • Overdose information on Acute liver failure • Carcinogenicity information on Acute liver failure • Acute liver failure in pregnancy • Pharmacokinetics of Acute liver failure • |
| Genetics, Pharmacogenomics, and Proteinomics of Acute liver failure | Genetics of Acute liver failure • Pharmacogenomics of Acute liver failure • Proteomics of Acute liver failure |
| Newstories on Acute liver failure | Acute liver failure in the news • Be alerted to news on Acute liver failure • News trends on Acute liver failure |
| Commentary on Acute liver failure | Blogs on Acute liver failure |
| Patient Resources on Acute liver failure | Patient resources on Acute liver failure • Discussion groups on Acute liver failure • Patient Handouts on Acute liver failure • Directions to Hospitals Treating Acute liver failure • Risk calculators and risk factors for Acute liver failure |
| Healthcare Provider Resources on Acute liver failure | Symptoms of Acute liver failure • Causes & Risk Factors for Acute liver failure • Diagnostic studies for Acute liver failure • Treatment of Acute liver failure |
| Continuing Medical Education (CME) Programs on Acute liver failure | CME Programs on Acute liver failure |
| International Resources on Acute liver failure | Acute liver failure en Espanol • Acute liver failure en Francais |
| Business Resources on Acute liver failure | Acute liver failure in the Marketplace • Patents on Acute liver failure |
| Informatics Resources on Acute liver failure | List of terms related to Acute liver failure |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
